The treatment and management of patients with coronary heart disease after myocardial revascularization

Abstract

This review present management and treatment of patients with coronary heart disease after percutaneous coronary intervention and coronary artery bypass grafting. Describes the main groups of drugs (antiplatelet agents, statins, beta-blockers, ACE inhibitorsj. Indicate the dates of the functional methods of research in the outpatient setting.